Literature DB >> 23669377

Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study).

A Alastruey-Izquierdo1, E Mellado, T Peláez, J Pemán, S Zapico, M Alvarez, J L Rodríguez-Tudela, M Cuenca-Estrella.   

Abstract

A population-based survey was conducted to investigate the epidemiology of and antifungal resistance in Spanish clinical strains of filamentous fungi isolated from deep tissue samples, blood cultures, and respiratory samples. The study was conducted in two different periods (October 2010 and May 2011) to analyze seasonal variations. A total of 325 strains were isolated in 29 different hospitals. The average prevalence was 0.016/1,000 inhabitants [corrected]. Strains were identified by sequencing of DNA targets and susceptibility testing by the European Committee for Antimicrobial Susceptibility Testing reference procedure. The most frequently isolated genus was Aspergillus, accounting for 86.3% of the isolates, followed by Scedosporium at 4.7%; the order Mucorales at 2.5%; Penicillium at 2.2%, and Fusarium at 1.2%. The most frequent species was Aspergillus fumigatus (48.5%), followed by A. flavus (8.4%), A. terreus (8.1%), A. tubingensis (6.8%), and A. niger (6.5%). Cryptic/sibling Aspergillus species accounted for 12% of the cases. Resistance to amphotericin B was found in 10.8% of the isolates tested, while extended-spectrum triazole resistance ranged from 10 to 12.7%, depending on the azole tested. Antifungal resistance was more common among emerging species such as those of Scedosporium and Mucorales and also among cryptic species of Aspergillus, with 40% of these isolates showing resistance to all of the antifungal compounds tested. Cryptic Aspergillus species seem to be underestimated, and their correct classification could be clinically relevant. The performance of antifungal susceptibility testing of the strains implicated in deep infections and multicentric studies is recommended to evaluate the incidence of these cryptic species in other geographic areas.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23669377      PMCID: PMC3697314          DOI: 10.1128/AAC.00383-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  46 in total

1.  Cryptic species in Stachybotrys chartarum.

Authors:  Michael Cruse; Robin Telerant; Thomas Gallagher; Thomas Lee; John W Taylor
Journal:  Mycologia       Date:  2002 Sep-Oct       Impact factor: 2.696

2.  EUCAST technical note on voriconazole and Aspergillus spp.

Authors:  W W Hope; M Cuenca-Estrella; C Lass-Flörl; M C Arendrup
Journal:  Clin Microbiol Infect       Date:  2013-02-15       Impact factor: 8.067

3.  Prevalence and susceptibility testing of new species of pseudallescheria and scedosporium in a collection of clinical mold isolates.

Authors:  Ana Alastruey-Izquierdo; Manuel Cuenca-Estrella; Araceli Monzón; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2006-11-13       Impact factor: 5.191

4.  Spectrum of zygomycete species identified in clinically significant specimens in the United States.

Authors:  E Alvarez; D A Sutton; J Cano; A W Fothergill; A Stchigel; M G Rinaldi; J Guarro
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

5.  Species identification and antifungal susceptibility patterns of species belonging to Aspergillus section Nigri.

Authors:  Laura Alcazar-Fuoli; Emilia Mellado; Ana Alastruey-Izquierdo; Manuel Cuenca-Estrella; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2009-07-27       Impact factor: 5.191

6.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

7.  Nonsporulating clinical isolate identified as Petromyces alliaceus (anamorph Aspergillus alliaceus) by morphological and sequence-based methods.

Authors:  S Arunmozhi Balajee; Mark D Lindsley; Naureen Iqbal; James Ito; Peter G Pappas; Mary E Brandt
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

8.  Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.

Authors:  D Neofytos; D Horn; E Anaissie; W Steinbach; A Olyaei; J Fishman; M Pfaller; C Chang; K Webster; K Marr
Journal:  Clin Infect Dis       Date:  2009-02-01       Impact factor: 9.079

9.  Amphotericin B-resistant Aspergillus flavus infection successfully treated with caspofungin, a novel antifungal agent.

Authors:  Tamara Koss; Bita Bagheri; Cosmina Zeana; Mario F Romagnoli; Marc E Grossman
Journal:  J Am Acad Dermatol       Date:  2002-06       Impact factor: 11.527

10.  Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure.

Authors:  Susan J Howard; Dasa Cerar; Michael J Anderson; Ahmed Albarrag; Matthew C Fisher; Alessandro C Pasqualotto; Michel Laverdiere; Maiken C Arendrup; David S Perlin; David W Denning
Journal:  Emerg Infect Dis       Date:  2009-07       Impact factor: 6.883

View more
  71 in total

1.  Aspergillus terreus infection in a sutureless self-sealing incision made during cataract surgery.

Authors:  Elif Erdem; Hazal Kandemir; Sevtap Arıkan-Akdağlı; Ebru Esen; Arbil Açıkalın; Meltem Yağmur; Macit İlkit
Journal:  Mycopathologia       Date:  2014-11-02       Impact factor: 2.574

2.  Investigation of Multiple Resistance Mechanisms in Voriconazole-Resistant Aspergillus flavus Clinical Isolates from a Chest Hospital Surveillance in Delhi, India.

Authors:  Cheshta Sharma; Rakesh Kumar; Nitin Kumar; Aradhana Masih; Dinesh Gupta; Anuradha Chowdhary
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

Review 3.  The Emerging Threat of Antifungal Resistance in Transplant Infectious Diseases.

Authors:  Ilan S Schwartz; Thomas F Patterson
Journal:  Curr Infect Dis Rep       Date:  2018-02-05       Impact factor: 3.725

4.  Fungal genotyping - current clinical application.

Authors:  Azian Harun
Journal:  Malays J Med Sci       Date:  2014 Nov-Dec

5.  An alternative host model of a mixed fungal infection by azole susceptible and resistant Aspergillus spp strains.

Authors:  L Alcazar-Fuoli; Mj Buitrago; A Gomez-Lopez; E Mellado
Journal:  Virulence       Date:  2015       Impact factor: 5.882

6.  Successful Treatment of Invasive Fungal Infection Due to Highly Resistant Aspergillus calidoustus in an Allogeneic Hematopoietic Cell Transplant Recipient.

Authors:  Maria A Mendoza; Anthony Anderson; Michele I Morris; Lazaros Lekakis; Jacques Simkins; Clara E Prado; Octavio V Martinez; Krishna V Komanduri; Jose F Camargo
Journal:  Mycopathologia       Date:  2020-01-10       Impact factor: 2.574

7.  In vitro combination of isavuconazole with micafungin or amphotericin B deoxycholate against medically important molds.

Authors:  Aspasia Katragkou; Matthew McCarthy; Joseph Meletiadis; Vidmantas Petraitis; Patriss W Moradi; Gittel E Strauss; Monique M Fouant; Laura L Kovanda; Ruta Petraitiene; Emmanuel Roilides; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2014-08-18       Impact factor: 5.191

Review 8.  Treatment of infections by cryptic Aspergillus species.

Authors:  Wagner L Nedel; Alessandro C Pasqualotto
Journal:  Mycopathologia       Date:  2014-09-13       Impact factor: 2.574

9.  Identification by Molecular Methods and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Antifungal Susceptibility Profiles of Clinically Significant Rare Aspergillus Species in a Referral Chest Hospital in Delhi, India.

Authors:  Aradhana Masih; Pradeep K Singh; Shallu Kathuria; Kshitij Agarwal; Jacques F Meis; Anuradha Chowdhary
Journal:  J Clin Microbiol       Date:  2016-07-13       Impact factor: 5.948

Review 10.  Multi-resistant aspergillosis due to cryptic species.

Authors:  Susan Julie Howard
Journal:  Mycopathologia       Date:  2014-06-27       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.